CLU (Clusterin) variants and mutations
CLU (also known as Clusterin) is a human protein-coding gene encoding a clusterin protein. It acts as an extracellular chaperone and participates in lipid transport, complement regulation, apoptotic-cell clearance, and responses to tissue injury. Common variation near CLU influences late-onset Alzheimer disease risk, and altered expression is observed in cardiovascular disease and cancer. This analysis covers 737 CLU variants and mutations. Of these, 83% have computational variant effect predictions. Disease context includes Alzheimer disease, dementia, and late-onset Alzheimers disease. Example CLU variants include M1?, M2V, and T4A.
Variant analysis overview
- Gene: CLU
- Protein: Clusterin
- UniProt accession: P10909
- Organism: Homo sapiens
- Variants analyzed: 737
- Variant scope: all variants
- Completed: 2026-08-21
Variant and mutation evidence
- Variant composition: 551 unspecified-consequence records; 1 stop retained variant; 5 stop-gained variants; 80 missense variants; 2 splice-region variants; 78 synonymous variants; 13 frameshift variants; 2 in-frame insertions; 4 in-frame deletions; 1 substitution
- Prediction scores: 615 variants have prediction scores (83% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: Alzheimer disease, dementia, late-onset Alzheimers disease, prostate cancer, dengue disease, neurodegenerative disease, Lewy body dementia, Hypermetropia, Abnormality of refraction, refractive error, breast cancer, myopia.
Protein structure and variant hotspots
- Protein features: 8 post-translational modification sites.
- PTM context: 11 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable CLU variants
Examples include M1?, M2V, T4A, T4I, L5A, L6Q, L6V, F8L. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1?, cosmic curated COSV10032
- M2V (p.Met2Val), cosmic curated COSV10814
- T4A (p.Thr4Ala), TOPMed rs1190119879, gnomAD rs1190119879, REVEL 0.04, CADD 18.20
- T4I (p.Thr4Ile), gnomAD rs1229727998, REVEL 0.07, CADD 20.60
- L5A (p.Leu5Ala), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- L6Q (p.Leu6Gln), TOPMed rs989659621, gnomAD rs989659621, REVEL 0.24, CADD 26.10
- L6V (p.Leu6Val), TOPMed rs1463321251, gnomAD rs1463321251, REVEL 0.14, CADD 22.80
- F8L (p.Phe8Leu), ExAC rs772400134, TOPMed rs772400134, gnomAD rs772400134, REVEL 0.09, CADD 8.83
- V9A (p.Val9Ala), ExAC rs745985571, gnomAD rs745985571, REVEL 0.15, CADD 23.00
- V9L (p.Val9Leu), gnomAD rs1443898354, REVEL 0.06, CADD 14.90
- L11M (p.Leu11Met), cosmic curated COSV57067
- L12V (p.Leu12Val), Ensembl rs2128910268
- W15* (p.Trp15Ter), cosmic curated COSV57067
- W15L (p.Trp15Leu), ESP rs150750334, ExAC rs150750334, TOPMed rs150750334, gnomAD rs150750334, REVEL 0.16, CADD 18.60
- W15R (p.Trp15Arg), 1000Genomes rs180798973, ExAC rs180798973, TOPMed rs180798973, gnomAD rs180798973, REVEL 0.20, CADD 22.50
- E16K (p.Glu16Lys), Ensembl rs1585256674, REVEL 0.14, CADD 22.00
- S17N (p.Ser17Asn), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- S17R (p.Ser17Arg), Ensembl rs11555227
- G18R (p.Gly18Arg), TOPMed rs1800904978, REVEL 0.25, CADD 22.70
- Q19K (p.Gln19Lys), TOPMed rs1488726582
- V20F (p.Val20Phe), NCI-TCGA Cosmic COSV1003, cosmic curated COSV10032, Variant assessed as somatic; moderate impact.
- V20G (p.Val20Gly), Ensembl rs1585256659
- V20I (p.Val20Ile), TOPMed rs1269799789, gnomAD rs1269799789, REVEL 0.15, CADD 23.20
- V20L (p.Val20Leu), TOPMed rs1269799789, gnomAD rs1269799789, REVEL 0.17, CADD 23.30
- L21P (p.Leu21Pro), NCI-TCGA Cosmic COSV1003, cosmic curated COSV10032, Variant assessed as somatic; moderate impact.
- L21R (p.Leu21Arg), ExAC rs748503484, TOPMed rs748503484, gnomAD rs748503484, REVEL 0.28, CADD 24.90
- L21V (p.Leu21Val), Ensembl rs754279494, REVEL 0.16, CADD 24.10
- G22E (p.Gly22Glu), TOPMed rs1800904233, gnomAD rs1800904233, REVEL 0.15, CADD 22.70
- D23N (p.Asp23Asn), gnomAD rs1800904153, REVEL 0.07, CADD 16.40
- D23V (p.Asp23Val), gnomAD rs1348991193, REVEL 0.07, CADD 16.30
- T25K (p.Thr25Lys), 1000Genomes rs543157739, ExAC rs543157739, TOPMed rs543157739, gnomAD rs543157739, REVEL 0.02, CADD 0.31
- T25M (p.Thr25Met), 1000Genomes rs543157739, ExAC rs543157739, TOPMed rs543157739, gnomAD rs543157739, REVEL 0.01, CADD 3.86
- T25R (p.Thr25Arg), 1000Genomes rs543157739, ExAC rs543157739, TOPMed rs543157739, gnomAD rs543157739, REVEL 0.03, CADD 1.73
- V26I (p.Val26Ile), rs1170008221, NCI-TCGA Cosmic COSV5706, cosmic curated COSV57067, gnomAD rs1170008221, REVEL 0.03, CADD 0.19, Variant assessed as somatic; moderate impact.
- S27* (p.Ser27Ter), NCI-TCGA TCGA novel, CADD 36.00, Variant assessed as somatic; high impact.
- N29S (p.Asn29Ser), TOPMed rs775044236, gnomAD rs775044236, REVEL 0.01, CADD 5.56
- N29T (p.Asn29Thr), TOPMed rs775044236, gnomAD rs775044236
- L31I (p.Leu31Ile), TOPMed rs1800903305, REVEL 0.33, CADD 24.20
- Q32H (p.Gln32His), ExAC rs750440670, TOPMed rs750440670, gnomAD rs750440670, REVEL 0.07, CADD 22.30
- E33G (p.Glu33Gly), NCI-TCGA Cosmic COSV5706, cosmic curated COSV57066, Variant assessed as somatic; moderate impact.
- E33Q (p.Glu33Gln), gnomAD rs1235465645, REVEL 0.15, CADD 23.60
- M34V (p.Met34Val), cosmic curated COSV57066
- N36D (p.Asn36Asp), 1000Genomes rs201809865, ExAC rs201809865, TOPMed rs201809865, gnomAD rs201809865, REVEL 0.01, CADD 3.31
- N36S (p.Asn36Ser), TOPMed rs1453425479, gnomAD rs1453425479, REVEL 0.01, CADD 2.47
- Q37* (p.Gln37Ter), TOPMed rs1800875959
- Q37K (p.Gln37Lys), TOPMed rs1800875959
- G38* (p.Gly38Ter), Ensembl rs2128909944
- K40T (p.Lys40Thr), TOPMed rs1330193914, gnomAD rs1330193914, REVEL 0.19, CADD 23.00
- Y41C (p.Tyr41Cys), gnomAD rs1390112562, REVEL 0.54, CADD 24.30
- V42A (p.Val42Ala), cosmic curated COSV57066
- V42I (p.Val42Ile), TOPMed rs1401195010, gnomAD rs1401195010, REVEL 0.01, CADD 0.46
- N43S (p.Asn43Ser), Ensembl rs939130413
- K44Q (p.Lys44Gln), TOPMed rs1800875423
- E45K (p.Glu45Lys), cosmic curated COSV57066
- E45Q (p.Glu45Gln), TOPMed rs1800875356
- Q47K (p.Gln47Lys), NCI-TCGA Cosmic COSV5706, cosmic curated COSV57067, Variant assessed as somatic; moderate impact.
- N48S (p.Asn48Ser), gnomAD rs1293674091, REVEL 0.35, CADD 25.30
- A49G (p.Ala49Gly), Ensembl rs2128909933, REVEL 0.46, CADD 26.00
- A49V (p.Ala49Val), cosmic curated COSV10441
- A49P (p.Ala49Pro), gnomAD 8-27600013-C-G, CADD 5.86
- V50A (p.Val50Ala), TOPMed rs113632015, gnomAD rs113632015, REVEL 0.27, CADD 24.20
- V50F (p.Val50Phe), cosmic curated COSV57068
- G52E (p.Gly52Glu), cosmic curated COSV10460
- G52R (p.Gly52Arg), cosmic curated COSV57066, ExAC rs747320736, gnomAD rs747320736, REVEL 0.31, CADD 27.40
- V53L (p.Val53Leu), NCI-TCGA Cosmic COSV5706, cosmic curated COSV57068, Variant assessed as somatic; moderate impact.
- K54E (p.Lys54Glu), ExAC rs779803164, TOPMed rs779803164, gnomAD rs779803164, REVEL 0.21, CADD 23.70
- Q55E (p.Gln55Glu), TOPMed rs759256899
- Q55K (p.Gln55Lys), TOPMed rs759256899
- I56M (p.Ile56Met), TOPMed rs1371918127, gnomAD rs1371918127, REVEL 0.20, CADD 9.51
- I56T (p.Ile56Thr), TOPMed rs1021437011
- K57N (p.Lys57Asn), ExAC rs771592746, gnomAD rs771592746, REVEL 0.33, CADD 24.10
- L59F (p.Leu59Phe), cosmic curated COSV10734
- T63A (p.Thr63Ala), rs138211435, 1000Genomes rs138211435, ESP rs138211435, ExAC rs138211435, REVEL 0.19, CADD 22.90, Variant assessed as somatic; moderate impact.
- T63K (p.Thr63Lys), cosmic curated COSV57067, REVEL 0.22, CADD 23.30
- N64K (p.Asn64Lys), cosmic curated COSV57067, ESP rs146277764, ExAC rs146277764, TOPMed rs146277764, REVEL 0.05, CADD 7.00, Likely benign
- N64S (p.Asn64Ser), ExAC rs777850013, gnomAD rs777850013, REVEL 0.06, CADD 13.10
- E65K (p.Glu65Lys), rs766667870, NCI-TCGA Cosmic COSV1003, cosmic curated COSV10032, ExAC rs766667870, REVEL 0.07, CADD 13.30, Variant assessed as somatic; moderate impact.
- E66* (p.Glu66Ter), cosmic curated COSV10032
- E66K (p.Glu66Lys), cosmic curated COSV57066
- R67C (p.Arg67Cys), cosmic curated COSV57067, TOPMed rs11555224, REVEL 0.26, CADD 24.00
- R67H (p.Arg67His), rs760456252, ExAC rs760456252, TOPMed rs760456252, gnomAD rs760456252, REVEL 0.06, CADD 16.30, Variant assessed as somatic; moderate impact.
- R67S (p.Arg67Ser), TOPMed rs11555224, REVEL 0.29, CADD 24.70
- K68R (p.Lys68Arg), cosmic curated COSV10032
- N73K (p.Asn73Lys), ExAC rs750597031, gnomAD rs750597031
- L74V (p.Leu74Val), TOPMed rs956433124, gnomAD rs956433124, REVEL 0.25, CADD 15.60
- E76A (p.Glu76Ala), ESP rs372043736, ExAC rs372043736, TOPMed rs372043736, gnomAD rs372043736, REVEL 0.14, CADD 24.40
- E76V (p.Glu76Val), ESP rs372043736, ExAC rs372043736, TOPMed rs372043736, gnomAD rs372043736, REVEL 0.15, CADD 24.90
- A77T (p.Ala77Thr), Ensembl rs1800872863
- K78R (p.Lys78Arg), ExAC rs777178481, TOPMed rs777178481, gnomAD rs777178481, REVEL 0.19, CADD 25.70
- K79M (p.Lys79Met), NCI-TCGA Cosmic COSV1003, cosmic curated COSV10032, Variant assessed as somatic; moderate impact.
- K80E (p.Lys80Glu), Ensembl rs1800872625
- E82A (p.Glu82Ala), TOPMed rs1800872386
- D83D (p.Asp83Asp), rs9331892, []
- A84S (p.Ala84Ser), TOPMed rs1800825494
- A84T (p.Ala84Thr), cosmic curated COSV57065
- L85I (p.Leu85Ile), cosmic curated COSV57068
- N86Y (p.Asn86Tyr), gnomAD rs1313161587
- E87D (p.Glu87Asp), TOPMed rs1800825325, NCI-TCGA Cosmic COSV5706, cosmic curated COSV57065, REVEL 0.06, CADD 2.90, Variant assessed as somatic; moderate impact.
- E90K (p.Glu90Lys), NCI-TCGA Cosmic COSV1003, cosmic curated COSV10032, Variant assessed as somatic; moderate impact.
- T93A (p.Thr93Ala), Ensembl rs1563387194
- L98F (p.Leu98Phe), Ensembl rs747405696
- P99A (p.Pro99Ala), ExAC rs772883860, gnomAD rs772883860, REVEL 0.05, CADD 13.00
- P99L (p.Pro99Leu), TOPMed rs1388938418, gnomAD rs1388938418, REVEL 0.08, CADD 21.70
- P99T (p.Pro99Thr), ExAC rs772883860, gnomAD rs772883860, REVEL 0.09, CADD 14.40
- G100E (p.Gly100Glu), gnomAD rs1205306982, REVEL 0.11, CADD 5.62
- V101L (p.Val101Leu), ExAC rs769302852, TOPMed rs769302852, gnomAD rs769302852
- V101M (p.Val101Met), ExAC rs769302852, TOPMed rs769302852, gnomAD rs769302852, REVEL 0.30, CADD 23.30
- C102F (p.Cys102Phe), 1000Genomes rs566482326, ExAC rs566482326, gnomAD rs566482326, REVEL 0.59, CADD 25.90
- C102R (p.Cys102Arg), gnomAD rs1249286988, REVEL 0.79, CADD 29.60
- E104K (p.Glu104Lys), NCI-TCGA Cosmic COSV5706, cosmic curated COSV57066, Variant assessed as somatic; moderate impact.
- T105I (p.Thr105Ile), ExAC rs754785720, TOPMed rs754785720, gnomAD rs754785720, REVEL 0.26, CADD 24.50
- T105S (p.Thr105Ser), ExAC rs754785720, TOPMed rs754785720, gnomAD rs754785720
- M106T (p.Met106Thr), ExAC rs773376852, gnomAD rs773376852, REVEL 0.35, CADD 23.40
- M106V (p.Met106Val), ExAC rs779145648, gnomAD rs779145648, REVEL 0.23, CADD 20.50
- M107I (p.Met107Ile), ExAC rs764173759, TOPMed rs764173759, gnomAD rs764173759, REVEL 0.05, CADD 11.90
- M107T (p.Met107Thr), ExAC rs754010296, gnomAD rs754010296, REVEL 0.07, CADD 0.31
- A108T (p.Ala108Thr), ExAC rs756152921, gnomAD rs756152921, REVEL 0.30, CADD 24.40
- L109F (p.Leu109Phe), gnomAD rs11555226, REVEL 0.37, CADD 25.60
- L109I (p.Leu109Ile), gnomAD rs11555226
- W110C (p.Trp110Cys), cosmic curated COSV10032
- E112A (p.Glu112Ala), TOPMed rs1461611022, gnomAD rs1461611022, REVEL 0.59, CADD 28.50
- E112D (p.Glu112Asp), ESP rs370131630, ExAC rs370131630, TOPMed rs370131630, gnomAD rs370131630, REVEL 0.28, CADD 23.10
- E112G (p.Glu112Gly), TOPMed rs1461611022, gnomAD rs1461611022, REVEL 0.61, CADD 32.00
- C113R (p.Cys113Arg), TOPMed rs1233946390, gnomAD rs1233946390, REVEL 0.78, CADD 29.70
- P115A (p.Pro115Ala), Ensembl rs1488320255
- Q119H (p.Gln119His), NCI-TCGA Cosmic COSV5706, cosmic curated COSV57068, Variant assessed as somatic; moderate impact.
- M122I (p.Met122Ile), cosmic curated COSV57066
- M122V (p.Met122Val), ExAC rs751945159, TOPMed rs751945159, gnomAD rs751945159, REVEL 0.08, CADD 16.30
- K123T (p.Lys123Thr), cosmic curated COSV57068
- F124I (p.Phe124Ile), NCI-TCGA Cosmic COSV5706, cosmic curated COSV57068, Variant assessed as somatic; moderate impact.
- Y125S (p.Tyr125Ser), Ensembl rs1800822870, REVEL 0.69, CADD 27.10
- Y125Y (p.Tyr125Tyr), rs9331898, Benign
- A126P (p.Ala126Pro), 1000Genomes rs138190443, ESP rs138190443, ExAC rs138190443, TOPMed rs138190443
- A126T (p.Ala126Thr), cosmic curated COSV10814, 1000Genomes rs138190443, ESP rs138190443, ExAC rs138190443, REVEL 0.18, CADD 21.60
- A126V (p.Ala126Val), ESP rs377249021, ExAC rs377249021, gnomAD rs377249021, REVEL 0.28, CADD 29.20
- R127C (p.Arg127Cys), cosmic curated COSV57067, ExAC rs769250405, TOPMed rs769250405, gnomAD rs769250405, REVEL 0.20, CADD 25.10
- R127H (p.Arg127His), rs761369634, NCI-TCGA Cosmic COSV5706, cosmic curated COSV57066, ExAC rs761369634, REVEL 0.17, CADD 23.30, Variant assessed as somatic; moderate impact.
- V128I (p.Val128Ile), rs150438413, ClinGen CA4690990, cosmic curated COSV10032, ClinVar RCV000901031, REVEL 0.16, CADD 19.70, Benign, not provided
- R130* (p.Arg130Ter), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- S133L (p.Ser133Leu), ExAC rs779845036, TOPMed rs779845036, gnomAD rs779845036, REVEL 0.48, CADD 32.00
- L135V (p.Leu135Val), ESP rs369037481, ExAC rs369037481, TOPMed rs369037481, gnomAD rs369037481, REVEL 0.10, CADD 20.00
- V136L (p.Val136Leu), cosmic curated COSV57067
- G137D (p.Gly137Asp), cosmic curated COSV57065
- R138C (p.Arg138Cys), ExAC rs757239189, TOPMed rs757239189, gnomAD rs757239189, REVEL 0.28, CADD 31.00
- R138H (p.Arg138His), rs756208273, NCI-TCGA Cosmic COSV1003, cosmic curated COSV10032, REVEL 0.11, CADD 13.70, Variant assessed as somatic; moderate impact.
- R138L (p.Arg138Leu), NCI-TCGA Cosmic COSV1003, cosmic curated COSV10032, Variant assessed as somatic; moderate impact.
- R138S (p.Arg138Ser), ExAC rs757239189, TOPMed rs757239189, gnomAD rs757239189, REVEL 0.17, CADD 26.80
- L140R (p.Leu140Arg), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- E141D (p.Glu141Asp), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- E141Q (p.Glu141Gln), Ensembl rs1800803152, REVEL 0.32, CADD 25.40
- E142D (p.Glu142Asp), gnomAD rs1370597528, REVEL 0.14, CADD 17.20
- E142K (p.Glu142Lys), cosmic curated COSV57065, REVEL 0.18, CADD 23.50
- F143I (p.Phe143Ile), gnomAD rs1270960934, REVEL 0.36, CADD 24.00
- L144M (p.Leu144Met), Ensembl rs1800802856
- N145K (p.Asn145Lys), gnomAD rs1343749062
- S148* (p.Ser148Ter), cosmic curated COSV57065
- S148A (p.Ser148Ala), gnomAD rs1318260275, REVEL 0.21, CADD 23.70
- S148L (p.Ser148Leu), cosmic curated COSV57065, TOPMed rs866333982, REVEL 0.30, CADD 24.70
- Y151C (p.Tyr151Cys), cosmic curated COSV57069
- F152Y (p.Phe152Tyr), ExAC rs758880085, gnomAD rs758880085, REVEL 0.23, CADD 24.10
- W153* (p.Trp153Ter), ExAC rs750766384, gnomAD rs750766384, CADD 37.00
- W153C (p.Trp153Cys), cosmic curated COSV57068, MetaLR 0.17, MetaSVM -0.79
- M154T (p.Met154Thr), gnomAD rs1474312346, REVEL 0.12, CADD 22.20
- M154V (p.Met154Val), ExAC rs765476640, TOPMed rs765476640, gnomAD rs765476640, REVEL 0.05, CADD 16.70
- N155Y (p.Asn155Tyr), gnomAD rs1241238645, REVEL 0.22, CADD 24.00
- G156S (p.Gly156Ser), ExAC rs756955136, gnomAD rs756955136, REVEL 0.38, CADD 24.50
- G156V (p.Gly156Val), TOPMed rs1800801665, MetaLR 0.42, MetaSVM -0.15
- D157E (p.Asp157Glu), TOPMed rs934124362, gnomAD rs934124362, REVEL 0.13, CADD 16.80
- D157G (p.Asp157Gly), gnomAD rs1486647949, MetaLR 0.33, MetaSVM -0.41
- R158C (p.Arg158Cys), cosmic curated COSV57066, REVEL 0.34, CADD 27.50
- R158H (p.Arg158His), ExAC rs772557487, TOPMed rs772557487, gnomAD rs772557487, REVEL 0.22, CADD 25.30
- R158L (p.Arg158Leu), ExAC rs772557487, TOPMed rs772557487, gnomAD rs772557487, REVEL 0.19, CADD 24.80
- R158S (p.Arg158Ser), cosmic curated COSV57068
- D160N (p.Asp160Asn), NCI-TCGA TCGA novel, Ensembl rs1800801175, REVEL 0.21, CADD 25.30, Variant assessed as somatic; moderate impact.
- S161F (p.Ser161Phe), ExAC rs775465384, gnomAD rs775465384, REVEL 0.12, CADD 25.40
- S161Y (p.Ser161Tyr), ExAC rs775465384, gnomAD rs775465384, REVEL 0.14, CADD 25.10
- E164G (p.Glu164Gly), NCI-TCGA Cosmic COSV1003, cosmic curated COSV10032, Variant assessed as somatic; moderate impact.
- E164Q (p.Glu164Gln), Ensembl rs1702535408, MetaLR 0.07, MetaSVM -1.08
- N165K (p.Asn165Lys), ExAC rs767422699, TOPMed rs767422699, gnomAD rs767422699, REVEL 0.05, CADD 0.70
- D166N (p.Asp166Asn), TOPMed rs1008354423, gnomAD rs1008354423, REVEL 0.11, CADD 20.50
Public CLU analysis runs
- CLU analysis run — CLU (737 variants) — completed 2026-08-21